Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

JAMA - Journal of the American Medical Association - Tập 311 Số 19 - Trang 1998 - 2014
Mark G. Kris1, Bruce E. Johnson2, Lynne D. Berry3, David J. Kwiatkowski4, A. John Iafrate5, Ignacio I. Wistuba6, Marileila Varella‐Garcia7, Wilbur A. Franklin7, Samuel L. Aronson8, Pei-Fang Su3, Yu Shyr3, D. Ross Camidge7, Lecia V. Sequist5, Bonnie S. Glisson6, Fadlo R. Khuri9, Edward B. Garon10, William Pao3, Charles M. Rudin11, Joan H. Schiller12, Eric B. Haura13, Mark A. Socinski14, Keisuke Shirai15, Heidi Chen3, Giuseppe Giaccone16,17, Marc Ladanyi1, Kelly Kugler7, John D. Minna12, Paul A. Bunn7
1Memorial Sloan Kettering Cancer Center, New York, New York
2Dana-Farber Cancer Institute, Boston, Massachusetts
3Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
4Brigham and Women's Hospital, Boston, Massachusetts
5Massachusetts General Hospital, Boston
6The University of Texas MD Anderson Cancer Center, Houston
7University of Colorado Cancer Center Denver, Aurora
8The Partners HealthCare Center for Personalized Genetic Medicine, Boston, Massachusetts
9Winship Cancer Institute of Emory University, Atlanta, Georgia
10David Geffen School of Medicine, University of California - Los Angeles.
11The John Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland
12University of Texas, Southwestern Medical Center, Dallas
13H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida
14University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania
15Medical University of South Carolina, Charleston
16National Cancer Institute, Bethesda, Maryland;
17National Cancer Institute, Bethesda, Maryland17Georgetown University School of Medicine, Washington, DC

Tóm tắt

Từ khóa


Tài liệu tham khảo

Thông tin
Thông tin xuất bản

JAMA - Journal of the American Medical Association

Tập 311 Số 19

1998

Thông tin tác giả